top of page

Stefan Schille


After receiving his Ph.D. degree in infection immunology from the Johannes Gutenberg University in Mainz, Dr. Stefan Schille joined BioNTech in 2019, where he works as a senior scientist.

His research at BioNTech focuses on the pre-clinical development of mRNA-based vaccines against infectious diseases, which includes optimizing antigens for improved antigen- presentation and advancing mRNA delivery systems.

bottom of page